Riboflavin
Showing 1 - 25 of 347
Muscle Soreness Trial in San Antonio (Riboflavin, Placebo)
Not yet recruiting
- Muscle Soreness
- Riboflavin
- Placebo
-
San Antonio, TexasThe University of Texas Health Science Center at San Antonio
Jun 8, 2023
Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry
Completed
- Dry Eye Disease
- modified hyaluronic acid 0.1% covalently linked to Riboflavin
- hyaluronic acid 0.1%
-
NAples, ItalyUniversity of Naples Federico II
Nov 2, 2023
Blood Pressure, Hypertension Trial in Coleraine (Placebo, Riboflavin 1.6mg/d, Riboflavin 5mg/d)
Enrolling by invitation
- Blood Pressure
- Hypertension
- Placebo
- +3 more
-
Coleraine, Co.Londonderry, United KingdomHuman Intervention Studies Unit, Ulster University
Aug 4, 2022
Psoriasis Trial in Ann Arbor (Riboflavin, Placebo)
Completed
- Psoriasis
- Riboflavin
- Placebo
-
Ann Arbor, MichiganUniversity of Michigan Department of Dermatology
Jul 5, 2022
Keratoconus, Corneal Ectasia Trial in Teaneck (Riboflavin/Dextran, Hypotonic Riboflavin)
Active, not recruiting
- Keratoconus
- Corneal Ectasia
- Riboflavin/Dextran
- Hypotonic Riboflavin
-
Teaneck, New JerseyCornea and Laser Eye Institute
Mar 7, 2022
Keratoconus Trial in Catanzaro, Firenze, Messina (Riboflavin/UV-A corneal cross-linking)
Recruiting
- Keratoconus
- Riboflavin/UV-A corneal cross-linking
-
Catanzaro, Italy
- +2 more
Jul 13, 2022
Keratoconus Trial in London (Collagen cross-linking with hypotonic riboflavin)
Completed
- Keratoconus
- Collagen cross-linking with hypotonic riboflavin
-
London, Greater London, United KingdomMoorfields Eye Department at St George's Hospital
Apr 4, 2022
Keratitis, Corneal Ulcer Trial in United States (PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial
Recruiting
- Keratitis
- Corneal Ulcer
- PXL Platinum 330 system + Riboflavin 0.25% TE Solution
- Sham CXL + Artificial Tears
-
Tampa, Florida
- +7 more
Jul 13, 2022
Corneal Neovascularization Trial in Indianapolis (30 minute photoactivation of riboflavin 0.1%, 10 minute photoactivation of
Recruiting
- Corneal Neovascularization
- 30 minute photoactivation of riboflavin 0.1%
- 10 minute photoactivation of riboflavin 0.1%
-
Indianapolis, IndianaPrice Vision Group
Jul 27, 2022
Keratitis, Corneal Ulcer Trial in United States (Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution, Standard of Care
Recruiting
- Keratitis
- Corneal Ulcer
- Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution
- Standard of Care Therapy + Sham CXL + Artificial Tears
-
Tampa, Florida
- +7 more
Jul 13, 2022
Keratoconus, Corneal Ectasia Trial in Teaneck (Riboflavin)
Active, not recruiting
- Keratoconus
- Corneal Ectasia
- Riboflavin
-
Teaneck, New JerseyCornea and Laser Eye Institute
Mar 7, 2022
Quality of Life Trial in Cork (Riboflavin)
Recruiting
- Quality of Life
- Riboflavin
-
Cork, IrelandAtlantia Food Clinical Trials, 1st Floor, Block C, Heron House,
Mar 27, 2023
Alcohol Withdrawal, Nutrition Disorders, Alcohol Use Disorder Trial (Riboflavin, Placebo)
Not yet recruiting
- Alcohol Withdrawal
- +2 more
- Riboflavin
- Placebo
- (no location specified)
Sep 27, 2021
Keratoconus, Corneal Ectasia Trial in Teaneck (Riboflavin)
Recruiting
- Keratoconus
- Corneal Ectasia
- Riboflavin
-
Teaneck, New JerseyCornea and Laser Eye Institue - Hersh Vision Group
Aug 23, 2021
Keratoconus Trial (Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146%)
Not yet recruiting
- Keratoconus
- Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% with UV light
- Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% without UV light
-
Boston, MassachusettsMassachusetts Eye and Ear Infirmary
Jan 12, 2023
Infectoius Keratitis Trial in Sohag (Riboflavin, Antibotice.g vigamox ED Antifungal e.g Dflucan, pack cross linking)
Not yet recruiting
- Infectoius Keratitis
- Riboflavin
- +2 more
-
Sohag, EgyptSohag University Hospital
May 29, 2023
Keratoconus, Pellucid Marginal Corneal Degeneration, Corneal Degeneration Trial in Dallas (PXL-330 Platinum device for
Recruiting
- Keratoconus
- +3 more
- PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
-
Dallas, TexasCornea Associates of Texas
Mar 7, 2022
Stroke Trial in Saint Petersburg (Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo)
Recruiting
- Stroke
- Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
- Placebo
-
Saint Petersburg, Russian Federation
- +2 more
Jul 7, 2023
Crohn's Disease, Oral Ulcer Trial in Xi'an (Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection)
Withdrawn
- Crohn's Disease
- Oral Ulcer
- Mesalazine Sustained-Release Tablets
- Riboflavin Sodium Phosphate Injection
-
Xi'an, Shaanxi, ChinaXijing Hospital
Jan 30, 2023
Progressive Keratoconus Trial in Lund (Corneal crosslinking: CXL (UVA 9mW/cm2), Isotonic riboflavin, Hypotonic riboflavin)
Recruiting
- Progressive Keratoconus
- Corneal crosslinking: CXL (UVA 9mW/cm2)
- +3 more
-
Lund, Skåne, SwedenSkåne University Hospital
Oct 14, 2021
Keratoconus Trial in Napoli (accelerated custom-fast CXL, Standard CXL)
Completed
- Keratoconus
- accelerated custom-fast CXL
- Standard CXL
-
Napoli, ItalyPellegrini Hospital
Aug 24, 2021
Keratoconus, Corneal Ectasia Trial in Teaneck (Riboflavin)
Recruiting
- Keratoconus
- Corneal Ectasia
- Riboflavin
-
Teaneck, New JerseyCornea and Laser Eye Institute, Hersh Vision Group
Aug 24, 2021
Keratoconus, Unstable Trial (Riboflavin)
Not yet recruiting
- Keratoconus, Unstable
- Riboflavin
- (no location specified)
May 21, 2021
Keratoconus, Ectasia Trial in New York (UVA Light with irradiance exposure of 9 mW/cm2, Riboflavin 0.1% ophthalmic solution)
Recruiting
- Keratoconus
- Ectasia
- UVA Light with irradiance exposure of 9 mW/cm2
- Riboflavin 0.1% ophthalmic solution
-
New York, New YorkEdward Harkness Eye Institute-Columbia University Medical Center
Aug 18, 2021
Corneal Ectasia Trial (riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system, : 0.0% riboflavin ophthalmic
Withdrawn
- Corneal Ectasia
- riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system
- placebo: 0.0% riboflavin ophthalmic solution with the KXL system
- (no location specified)
Apr 22, 2021